Ultrasound-detected BI-RADS 3 lesions rarely malignant August 20, 2013 -- Breast lesions categorized as "probably benign" on supplemental screening ultrasound are rarely malignant and could be re-evaluated at 12 months rather than six -- reducing patient anxiety, follow-up exams, and unnecessary biopsies, according to a study published online in Radiology.
Study links triple-negative breast cancer on MRI, PET/CT scans August 9, 2013 -- California researchers have found links between the appearance of triple-negative breast cancer on two different imaging modalities, MRI and PET/CT. They believe their findings can help guide therapy for the disease, which occurs less frequently but is typically more deadly than other types of breast cancer.
GE takes aim at breast tomosynthesis market August 5, 2013 -- GE Healthcare has long been one of the top two mammography firms, but the company until now hasn't had an offering in the cutting-edge breast tomosynthesis segment. That is changing, however: The firm has begun shipping its SenoClaire tomosynthesis system in Europe and has put the final touches on a regulatory application in the U.S.